A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic… (NCT05909202) | Clinical Trial Compass
CompletedNot Applicable
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
United States28 participantsStarted 2024-06-05
Plain-language summary
Background:
People who receive an allogeneic hematopoietic stem cell transplant (HSCT) require long-term care at home afterwards. Their caregivers often experience high levels of stress, which can lead to symptoms such as depression, anxiety, poor sleep, fatigue, and difficulties with concentration and memory.
Objective: To explore whether a nature-based immersive virtual reality (VR) program helps reduce stress in people who care for HSCT patients.
Eligibility:
People aged 18 and older who are primary caregivers of HSCT patients.
Design:
This is a two-phase study. Participants will be enrolled for 4 weeks. They will have 2 clinic visits.
Participants will have a physical exam at the beginning of the study. They will be asked to provide a saliva sample in Phase 1, and saliva and blood samples in Phase 2.
Participants will be given a VR headset. This is a device that looks like a pair of goggles worn over the eyes. They will be asked to wear the headset for 20 minutes per day. They will see 360 (Infinite) high-definition videos of nature and hear nature sounds.
Participants will record the time they spend using the VR headset in a daily diary. They will take surveys with questions about any stress and symptoms they feel once a week. This will take up to 5 minutes. Participants will have a short regular follow-up visit by phone one week after starting their participation.
At the end of the intervention study, participants will return for another physical exam. They will give saliva and/or blood samples again.
Researchers will also look at the medical records of the HSCT patients; the HSCT patients must consent to this....
Who can participate
Age range18 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Ability to understand and the willingness to sign a written informed consent document.
✓. Age 18 years and older.
✓. Serving as a primary caregiver\* for an adult patient (18 years and older) planning to undergo their 1st allogeneic HSCT at the NIH Clinical Center during the four-week study period.
✓. Ability to read, speak and understand English.
✓. Access to necessary resources for participating in online survey (i.e., computer, laptop, tablet, smartphone, internet access).
✓. Ability to understand and the willingness to sign a written informed consent document.
✓. Age 18 years and older.
✓. Planning to undergo their 1st allogeneic HSCT at the NIH Clinical Center during the four-week study period.
Exclusion criteria
✕. Serving as a paid caregiver for the patient.
What they're measuring
1
Changes in perceived stress
Timeframe: 4 weeks
Trial details
NCT IDNCT05909202
SponsorNational Institutes of Health Clinical Center (CC)
✕. Recent use of immersive VR programs for stress relief and/or entertainment (more than 2 days/week within the past 3 months). \*
✕. Participation in another stress-reduction type interventional study within the past 3 months.
✕. Having a medical condition that is prone to frequent nausea or dizziness.
✕. Current or past history of seizure, chronic migraines, epilepsy, claustrophobia, panic disorder, post-traumatic stress disorder, generalized anxiety disorder, major depressive disorder or other known severe neurological or mental health disorders.
✕. Being sensitive to flashing light or motion.
✕. Having a balance disorder such as vertigo and cybersickness.